4//SEC Filing
Jacobs Ian Seth 4
Accession 0001213900-24-094680
CIK 0001900520other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:33 PM ET
Size
5.3 KB
Accession
0001213900-24-094680
Insider Transaction Report
Form 4
Jacobs Ian Seth
DirectorPresident, CEO, CFO, Secretary10% Owner
Transactions
- Other
Common Stock
2024-11-01−75,000→ 175,000 total
Footnotes (1)
- [F1]As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.
Documents
Issuer
Lomond Therapeutics Holdings, Inc.
CIK 0001900520
Entity typeother
Related Parties
1- filerCIK 0001707297
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:33 PM ET
- Size
- 5.3 KB